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Abstract 
Background:Obesity has become a worldwide epidemic and is associated with impaired quality of life. It is now a 
major health concern in our country contributing significantly to increased morbidity and mortality, reducing life 
expectancy markedly among adults, and is commonly associated with hypertension. It causes mechanical 
obstruction of various parts of the body, including the respiratory system.Materials and Methods: A Total of three 
hundred (300) age and sex matched subjects were selected from those attending the Executive Health Check up 
OPD of kannur Medical College , which included One hundred (100) normal subjects (Group 1), One hundred (100) 
obese normotensive subjects (Group 2), and One hundred (100) obese hypertensive subjects (Group 3). Results:In 
the obese normotensive group and obese hypertensive group, statistically significant decline in FVC was seen as 
compared to the non-obese group. But there was no significant change in FVC between the hypertensive obese and 
normotensive obese groups . FEV1 showed no significant difference between regular, obese normotensive and obese 
hypertensive groups, although the obese groups showed a small insignificant decrease. FEV1/FVC % did not show 
any significant change in the three groups.  PEF did not show any significant change in the three 
groups.Conclusion:It can be concluded that obesity causes mechanical restriction to respiratory movements  which 
adversely affect pulmonary functions. Hypertension had no adverse effects on lung functions. 
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Introduction 
 
Obesity is a public health problem worldwide, with a 
growing occurrence and prevalence and just over a 
century old. The impact of obesity on the quality of life 
was recorded in the 18th century, but it was recognised 
as a cause of disintegrating health only in the middle of 
the 19th century, and its adverse role in increased 
morbidity and mortality was documented only in the  
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first decades of the 20th century. The exponential rise in 
obesity incidence has led the World Health 
Organization to label it a Global Epidemic over the last 
sixty years. The indolent development of complications-
hypertension, diabetes mellitus and atherosclerosis is 
responsible for morbidity and mortality[1].Obesity is 
one of the most prevalent forms of malnutrition and is a 
major contributor to ill health. It is defined as an 
abnormal growth of adipose tissue due to an increase in 
fat cell size (hypertrophic obesity) or an increase in the 
number of fat cells (hyperplastic obesity), or a 
combination of the two. Obesity is frequently expressed 
in terms of the Body Mass Index (BMI), a simple index 
used to classify adult obesity, overweight, and 
underweight. BMI is defined as the weight in kilograms 
International Journal of Health and Clinical Research, 2020;3(6):166-174                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
____________________________________________________________________________________________________________________________________________ 
Sreedharan et al            International Journal of Health and Clinical Research, 2020;3(6):166-174 
www.ijhcr.com   
  
                         
                    167 
  
divided by the square of the height of the person in 
metres (kg/m2). BMI > 30.0 kg/m2 is classified as 
obesity and the BMI between 18.50 to 24.99 kg/m2 is 
taken as the normal range[2]. Obesity gives additional 
strain to the cardio- respiratory system[3].  It is linked 
to hypertension, dyslipidemia, ishemic heart disease, 
diabetes mellitus, osteoarthritis, liver disease and 
respiratory anomalies[4]. As far as respiration is 
concerned, birth involves sudden transfer from a 
situation in which no breathing effort is necessary to 
one in which continued breathing effort is 
indispensible[5]. Obesity can alter respiratory 
physiology leading to resistance abnormalities, 
ventilation and perfusion relationships, respiratory 
muscle workload, upper airway calibre & tone, 
ventilation control, and Compliance of  pulmonary and 
chest walls[6]. Obesity affects various respiratory 
parameters such as compliance, neuromuscular strength, 
breathing work, spirometric measurements, respiratory 
resistance, diffusing capacity and exchange of gases, 
and reduces respiratory muscle strength and respiratory 
muscle efficiency, particularly that of the  diaphragm. A 
possible cause of impaired respiratory function in 
obesity includes increased elastic load which must be 
overcome by the respiratory muscles during inspiration. 
An overstretched diaphragm would place this 
respiratory muscle at a mechanical disadvantage, 
resulting in reduced muscle strength and efficiency of 
inspiration. Extremely obese subjects have a tendency 
towards rapid and shallow breathing to overcome the 
reduced total respiratory compliance and inefficiency of 
the respiratory muscles. Obesity increases the oxygen 
consumption by the muscles and the airway resistance. 
Obese people may be predisposed to respiratory failure 
during situations that tax the respiratory system 
further[7],As age advances there is variability in 
pulmonary functions such as Forced Vital Capacity 
(FVC), Forced Expiratory Volume in 1st Second 
(FEV1), Functional Residual Capacity (FRC), Residual 
Volume (RV), etc[8]. The changes in the parameters of 
the pulmonary function are mild, but may become 
significant in people with obesity. The study conducted 
by Rubinstein I et al in obese, non-smoking men found 
a restrictive ventilatory impairment, with reduction in 
forced expiratory volume in 1st second (FEV1), Forced 
Vital Capacity (FVC), Total Lung Capacity (TLC), 
Functional Residual Capacity (FRC), and Expiratory 
Reserve Volume (ERV)[9]. Obesity and weight gain are 
independent risk factors for developing hypertension. 
Hypertension is associated with weight gain in people 
with previously normal blood pressure and lowering of 
arterial blood pressure on weight loss is seen in 
hypertensive obese persons[10]. Clinic blood pressure 
of 140/90 mm Hg is recommended for diagnosing 
hypertension[11].   Systemic hypertension leads to left 
ventricle pressure overload which predisposes to 
concentrated left ventricular hypertrophy occurring with 
volume overload conditions alone. Mixed pressure and 
volume overload leads to increased left ventricle wall 
stress.Diastolic dysfunction is common in obese 
subjects, and the risk of systolic dysfunction increases 
with coexisting hypertension. Systolic dysfunction or 
cardiomyopathy due to obesity results if the degree of 
hypertrophy does not keep pace with that of chamber 
dilatation[12].Pulmonary function tests are an essential 
part of clinical practice[13]. Spirometry is the most 
common method for measuring pulmonary function 
tests. Lung functions especially the amount (volume) 
and/or speed (flow) of air that can be exhaled or inhaled 
can be measured[14].Obesity is considered the most 
common factor that affects the relationship between the 
lungs, chest wall and diaphragm, leading to significant 
affects in pulmonary function values that can be 
measured by spirometry. Shashi Mahajan et al. studied 
the pulmonary function tests of normal non-obese 
Amritsar males and obese Amritsar males and found a 
decrease in obese group Forced Vital Capacity 
compared to non-obese group[15].In the present study, 
an attempt will be made to study the adverse effects of 
obesity and hypertension on selected parameters of 
pulmonary function tests using a computerised 
spirometer.  
 
Objectives  
 To study the effects of obesity on pulmonary 
functions FVC, FEV1, FEV1/FVC% and PEF in 
40-60 year old obese, non-hypertensive male 
subjects comparing them with normal controls 
using a computerised spirometer.  
 To study the effects of obesity on pulmonary 
functions FVC, FEV1, FEV1/FVC% and PEF in 
40-60 year old obese, hypertensive male subjects 
comparing them with controls using a 
computerised spirometer.  
 To study the effects of hypertension on pulmonary 
functions FVC, FEV1, FEV1/FVC%, and PEF in 
40-60 year old obese, hypertensive male subjects 
comparing them with obese normotensive male 
subjects of the same age group.           
 
 
International Journal of Health and Clinical Research, 2020;3(6):166-174                e-ISSN: 2590-3241, p-ISSN: 2590-325X                         
                                                             
____________________________________________________________________________________________________________________________________________  
____________________________________________________________________________________________________________________________________________ 
Sreedharan et al            International Journal of Health and Clinical Research, 2020;3(6):166-174 
www.ijhcr.com   
  
                         
                    168 
  
Materials and methods 
 
This study is a comparative study of pulmonary 
functions of obese normotensive male subjects and 
obese hypertensive male subjects with normal male 
subjects of 40-60 years age group. Study was conducted 
in the Department of Physiology and Department of 
Chest Medicine, Kannur Medical College, Anjarakandy,  
Kannur, on subjects who came to Kannur Medical 
College Hospital OPD for Executive Health Check-up. 
Pulmonary functions tests were performed on 300 male 
subjects who were divided into 3 groups.   
 100 normal subjects(group 1)  
 100 obese normotensive subjects(group 2) and   
 100 obese hypertensive subjects (group 3).  
The differences in the values of parameters FVC, FEV1, 
FEV1/FVC% and PEF between the groups were 
analyzed and discussed. 
Inclusion criteria  
 Male subjects 40-60years of age with BMI between 
18.5-24.9 kg/m2 who are  normotensive ( assumed 
blood pressure ≤ 120mm Hg systolic and ≤ 80mm 
Hg diastolic)[16] 
 Male subjects 40-60years with BMI ≥ 30kg/m2, 
who are normotensive. Male subject’s 40-60years 
with BMI ≥ 30kg/m2and are hypertensive (blood 
pressure ≥ 140/90mm Hg).  
Exclusion criteria  
 Male subjects with evidence of     
cardiopulmonary diseases.  
 Female subjects.  
 Smokers.  
Ethical clearance was obtained from the Kannur 
Medical College Ethical Clearance Committee for 
Human Research to conduct the study.  Health status of 
the subjects were ascertained through history taking and 
clinical examination before recording the spirogram. 
Written informed consent was taken from each subject 
before conducting the pulmonary function tests .Weight 
(kg) was measured using a calibrated weighing machine 
in light clothing and bare feet using the same weighing 
machine for all subjects and height (cms) was measured 
using a centimetre measuring scale attached to the wall. 
Using the formula BMI = Weight in kg / Height2 (ms) 
was calculated. 
Method of recording of Blood Pressure  
Blood Pressure was recorded  in resting state by  using 
the same sphygmomanometer for all the subjects. 
Subjects with blood pressure ≥140mmHg systolic and 
≥90 mmHg diastolic were taken as hypertensives and 
they had their blood pressure taken in two sessions.  
The subjects' systolic and diastolic blood pressure was 
measured in the right arm using the sphygmomanometer 
in the lying position after a rest of 15 minutes.BPL 
ARPEMIS handheld Personal Computer based 
spirometer was used to test the lung functions. BPL 
ARPEMIS is a serial contact spirometer based on 
Windows 95/98. This spirometer has a mouthpiece 
attached to the  transducer assembly which is connected 
by a cable to the Computer. Software of BPL 
ARPEMIS Healthcare group, BPL Ltd was installed in 
the computer. This software allows the predicted values 
for age, sex and height, and it also gives a recorded 
value of all the parameters. To enhance patient 
performance, BPL ARPEMIS has a unique feature, a 
WATER TANK for patient motivation. Since 
spirometry is a voluntary test, it requires maximum 
effort and co-operation from the patient. Lay people are 
neither used to nor aware of spirometry. When you 
input the relevant data, the screen changes to the FVC 
test. Instead of predicted values being displayed a water 
tank with 3 level colours will be seen. All you have to 
ask the patient to do is to fill the water tank with blue 
water with his expires when the red button turns to 
green. The more he expires the more respective levels 
are overwritten with blue water.  
The level colours:  
 Red = 0-60% of   predicted FVC.  
Yellow = 60-80% of predicted FVC.  
Green = 80-100% of predicted FVC.  
After proper guidance and practise with nose clips in 
place and lips tightly placed around the sterilised and 
reusable mouthpiece in the sitting posture, the subject 
was asked to inspire with maximum effort and then 
expire quickly and with maximum force into the mouth 
piece. Three trials were performed and the best of the 
three spirograms was selected and the best value of the 
following parameters FVC, FEV1, FEV1/FVC% and 
PEF in each spirogram was considered for evaluation 
and comparison. The values of the various parameters 
are entered into the Microsoft Excel spreadsheet.BPL 
ARPEMIS is factory calibrated. It is recommended that 
calibration be done once in 6 months or as per usage. 
Statistical Analysis  
Data was entered in Microsoft Excel spreadsheet 2010. 
Data was analysed using the statistical software SPSS-
17th version.Microsoft Word 2010 version was used to 
generate graphs and tables. Using ANOVA, Kruskal 
Wallis H Test and Mann Whitney U Test the parameters 
FVC, FEV1, FEV1 / FVC percent, and PEF were 
analysed. FEV1 was analysed using ANOVA as the 
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assumption of normality was satisfied.FVC, FEV1/FVC 
and PEF were analysed using Kruskal Wallis H Test to 
find the significant difference between the three groups. 
Mann Whitney U test was used for pairwise 
comparisons. A p-value less than 0.05 has been found 
statistically significant. Graphs are those of Median 
except FEV1, which is that of Mean.  
 
Results 
 
The present study was conducted at the Department of 
Physiology and Chest Medicine, Kannur Medical 
College to record the pulmonary functions FVC, FEV1, 
FEV1 / FVC percent and PEF among 300 male subjects 
in the 40-60 year age group who attended Kannur 
Medical College OPD.The subjects of the study were 
split up into three classes. Groups 1, Groups 2 and 
3.Group 1 consisted of 100 normal subjects with the 
following characteristics in Mean ± SD. 
 
Table 1: General characteristic of Group1 (normal) study subjects 
 
Characteristics Mean ± SD 
Age in years  50.14 ± 6.65  
Weight in Kg  62.84 ± 8.63  
Height in cms  163.98 ± 6.78  
BMI in Kg/m2  23.33 ± 2.54  
SBP in mm Hg  123.14 ± 9.32  
DBP in mm Hg  78.50 ± 5.91  
 
Group 2 consisted of 100 obese normotensive subjects with the following characteristics 
 
Table 2: General characteristics of Group 2 (obesity without hypertension) study subjects  
Characteristics Mean ± SD 
Age in years  49.64 ± 6.73  
Weight in kg  84.22 ± 7.34  
Height in cms  164.34 ± 8.51  
BMI in kg/m2  30.98 ± 1.65  
SBP in mm Hg  127.70 ± 7.97  
DBP in mm Hg  81.66 ± 5.01  
 
Group 3 consisted of 100 obese hypertensive subjects with the following characteristics. 
Table 3: General characteristics of Group 3 (Obesity with hypertension) study subjects  
Characteristics Mean ± SD 
Age in years  48.47 ± 5.60  
Weight in Kg  84.62 ± 7.64  
Height in cms  163.61 ± 17.18  
BMI in Kg/m2  31.00 ± 2.10  
SBP in mm Hg  147 ± 5.98  
DBP in mmHg  93.20 ± 3.27  
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Age was not statistically significant among the three 
groups. The three groups are similar in age (40 – 60 
years) in terms of basic characteristics. Group 2 and 3 
showed significant differences in BMI compared to 
Group 1. The basic characteristics in Tables 1, 2 and 3 
indicate that there was statistically significant difference 
between group 1 and 3 subjects in SBP and DBP (p < 
0.001) but no substantial difference between group 1 
and group 2. 
 
 
Fig 1: FVC 
 
The FVC value of the three groups shown in Figure 1 
was found to be significantly different. FVC was found 
to be higher in Group 1 relative to Group 2 and Group 
3.The difference between Group 2 and Group 3 is not 
significant. Group 1 FVC values are significantly 
different from Group 2 (p-value < 0.001) and Group 3 
(p-value 0.005). However, there is no substantial 
average difference in FVC between Group 2 and Group 
3 should use as the p-value obtained for measuring 
variance between both groups is 0.068, which is > 
0.05.The range of median is expressed in terms of Inter 
Quartile Range (IQR)  
 
 
Fig 2: FEV1 
 
The FEV1 values between the 3 groups were not found to be significantly different.Between the regular group (group 
1) and the obese groups (groups 2 and 3) there was a small insignificant decrease in FVC. 
 
Fig  3: FEV1/FVC 
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There was no substantial improvement in the percentage 
of FEV1 / FVC between the three groups, and no 
significant difference between the hypertensive obese 
and non hypertensive obese groups. 
 
Fig 4: PEF 
 
The PEF value was not significantly different in the three groups. 
 
Discussion 
 
In this study males of age group of 40-60 years were 
selected because of the influence of the middle-east, 
which is very vividly seen in the population of North 
Kerala. Males employed in the countries of the Middle 
East are often used for the unhealthy and irresponsible 
consumption of calorie-rich and easily available fast 
food and standardised working profile with a sedentary 
lifestyle, making them more likely to become obese.In 
the present research, a significant decrease in the level 
of Forced Vital Capacity (FVC) was noted in the obese 
normotensive and obese hypertensive groups 2 and 3 
compared with their matched controls, group 1, and this 
confirms earlier studies. But the FVC did not indicate 
any significant difference between group 2 and group 3. 
The significant reduction in the level of FVC in the 
obese groups 2 and 3 compared to group 1 can be 
attributed to the restrictive effect of obesity. There was 
no significant reduction in lung function parameter FVC 
specifically due to hypertension possibly due to the fact 
that these are newly detected cases and long standing 
hypertension has effect on lung functions.  
FVC and FEV1  
In support of this study, Ray CS et al[17], Refsum HE 
et al[18] and Bottai M et al[19] demonstrated an 
increase in lung function FVC by losing weight that 
indicates the negative effects of obesity, and that these 
effects do not involve permanent structural remodelling 
of the airways. Changes of reduced FVC similar to the 
present study was found in the study conducted by 
Rubinstein I et al. on obese non smoking men. This is 
thought to be a consequence of the mechanical strain on 
the chest wall and diaphragm, which in turn decreases 
thoracic compliance and impedes diaphragmic descent. 
Rubinstein and colleagues have found that obese people 
have significantly higher airway resistance and lower 
FEV1 compared to non-obese people. Restrictive 
impairment can be seen here  [9].Some studies by Carey 
IM et al. have also shown a similar inverse association 
between FVC and BMI, which is more likely to be due 
to a greater central distribution of fat in men than in 
women[20]Earlier research by Biring MS et al. supports 
the adverse effects of obesity, in which significant 
improvements were found in the study on pulmonary 
physiological changes in obesity. FVC was reduced in 
the obese community and indicated that obesity could 
cause airflow restriction with reduction in both FVC 
and FEV1 and that FEV1 and FVC were symmetrically 
reduced in this study[21]Study conducted by Raida I et 
al. on the socioeconomic factors or racial difference in 
lung function in Maryland showed that the reduced 
FVC observed in obesity was more in men than among 
women. Education had less impact than the index of 
poverty in accounting for the racial disparity between 
white and Afro-American women and BMI was 
inversely associated with FEV1 and FVC[22].Our 
studies showed only an insignificant reduction in FEV1 
like the study done in UK by Canopy D et al[23].On the 
contrary, a research conducted in Saudi Arabia by 
Mohammed Al Hoban did not show reduced FVC and 
FEV1, which may be due to wide variance in PFT 
values in the ethnicity of different populations or may 
be the result of differing methodologies in the 
research[24].Our analysis shows a substantial reduction 
in FVC in the obese normotensive and obese 
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hypertensive groups compared with the usual group due 
to the impact of obesity but no significant difference in 
FVC between the two groups as hypertension does not 
appear to have any adverse effect here.Our study shows 
a slight reduction in FEV1 in obese normotensive and 
obese hypertensive groups 2 and 3 compared to normal 
group 1 and, at the same time, there is no important 
difference between group 2 and 3 because the effect of 
hypertension on lung function is not observed.Low 
values of FVC and slightly reduced FEV1 indicate a 
restrictive lung pattern among obese people. The cause 
of decline in these respiratory parameters in obesity 
may be due to reduced distensibility of the chest wall or 
limited expansion of the thoracic cavity. 
FEV1/FVC%  
In a study performed on 103 obese men, 
Rubinstein I et al. found that the FEV1 / FVC ratio is 
usually normal or increased[9]. This study was normal, 
as was the study described above. Possible cause can 
also involve obesity-related inflammation or small 
airway oedema, thus reducing their calibre. The 
increased ratio may be attributable to the peripheral 
closing of the airways and the resultant gas trapping, 
which may significantly reduce the FVC. The 
assumption is that, unlike in the present research, 
obesity can affect small airway function.A recent 
research by Leone et al. indicates that abdominal 
obesity may be associated with a reduced FVC / FEV1 
ratio suggesting an impact on the broad airway calibre, 
as well as suggesting that obesity may be associated 
with obstructive ventilatory abnormality in addition to 
its well-known association with restrictive 
abnormality[25].Study by Biring MS et al[21] 
demonstrated a preserved FEV1/FVC ratio which 
remains unaltered like this present study. 
 FVC and FEV1 were symmetrically reduced in 
the obese group probably due to airflow limitation 
suggesting a restrictive pattern. Our study shows near 
normal values in the obese groups, group 2 and 3 on the 
average. Several longitudinal studies indicate that this 
ratio with obesity is normal, or increased. This is due to 
peripheral gas trapping due to the peripheral closure of 
the airways and thus a substantial reduction of the FVC. 
The assumption is that while obesity can affect small 
airway functions it does not affect big airways.Similar 
to this study, a recent analysis performed by Sin DD et 
al[26], FVC and FEV1 are reduced symmetrically, 
resulting in a retained FEV1 / FVC ratio consistent with 
a restrictive model. Here it has been indicated that 
obesity can cause airflow limitation with both FEV1 
and FVC reduction.Shashi Mahajan et al. study showed 
negligible changes in FEV1 / FVC, as in this present 
analysis. Low FVC and FEV1 values indicate a 
restrictive pattern  among obese people[15].The cause 
of the decline in the respiratory parameters may be due 
to a reduction in the distensibility of the chest wall, 
causing changes in the volume and flow of 
ventilation.The study conducted by Mohammed Al 
Ghobain among the non-smoking obese and non-obese 
groups of the Saudi population did not show any 
significant differences in the FEV1:FVC ratio between 
these two groups[24]. But in this study there was no 
significant reduction in FVC and  FEV1.  
Peak Expiratory Flow (PEF)  
This analysis shows no major difference in the PEF 
values. On the contrary, GG King et al’s research 
showed a substantial reduction of the obese population, 
indicating the existence of air flow limitation in obese 
males[27]. Similar to this study, the study conducted by 
Shashi Mahajan et al[15] on lung functions in 
Amritsar's adult male population showed negligible 
changes in the obese group PEF values compared to 
normal groups.An association of hypertension with 
pulmonary functions can be expected because acute and 
chronic elevations of left atrial pressure due to 
hypertensive reduction of left ventricular compliance 
are known to cause elevation of pulmonary artery 
pressure which in turn may lead to a reduction in FEV1 
and FVC. The pulmonary functions FVC, FEV1 ,  
FEV1/ FVC percent and PEF are not reduced 
significantly specifically due to hypertension in this 
present study. Increased systemic and pulmonary 
vascular resistance and increased vessel stiffness can be 
associated with hypertension, but there is no substantial 
reduction in pulmonary functions FVC, FEV1, 
FEV1/FVC percent and PEF, possibly because these 
subjects are not long-standing hypertensive. Reduced 
FVC due to obesity precedes the onset of hypertension. 
Left ventricular thickness and therefore altered left 
ventricular preload to the left ventricular mass cause 
alterations in pulmonary function, however this only 
happens after long-standing hypertension.In this study 
there was a decline in FVC in obese normotensive and 
obese hypertensive subjects compared with standard 
controls. This observation indicates a restrictive pattern 
of obesity-related lung functions. There was no 
statistically significant difference between obese 
hypertensive and obese normotensive groups which 
means that hypertension does not play a significant role 
in this study.In this study, FEV1 was mildly reduced in 
the obese groups suggesting a restrictive disorder and 
there was no significant effect of hypertension on the 
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pulmonary functions.Therefore significantly reduced 
FVC, insignificant difference in FEV1, FEV1/FVC ratio 
and PEF indicates that obesity results in restrictive 
pulmonary disease and there is less element of 
obstructive pulmonary diseases.              
Conclusion  
The following conclusion can be drawn from the results 
of the present study. 
The FVC values in the Obese Normotensive and Obese 
Hypertensive Groups were substantially decreased 
relative to the regular group but there was no substantial 
difference between the Obese Hypertensive Group and 
the Obese Normotensive Group. There was no 
significant change in FEV1 / FVC% Compared with 
controls, there was no significant change in PEF values 
in both categories.Therefore significantly reduced FVC 
and mild reduction in FEV1 and insignificant changes 
in FEV1/FVC and PEF implies that obesity could result 
in a restrictive pattern of pulmonary disease. This study 
provides a glimpse into the variety of alterations in 
pulmonary functions even in the absence of overt 
disease in obese people and shows the vulnerability of 
obese people to respiratory impairment. At the same 
time hypertension did not show any significant 
alteration in pulmonary functions.A multidisciplinary 
effort must be taken to tackle the obesity epidemic. One 
should choose the most health friendly foods among our 
traditions and customs. Several methods like yoga, 
meditation, Indian dance forms, martial arts, jogging etc 
will make physical activity fun. The hazards of fast food 
culture and awareness of the quality of food consumed 
should be instilled at the community level. The 
Hippocrates quote, “Everything in excess is opposed by 
nature “aptly describes how in pursuing the ‘good life’ 
we have created an environment and society that 
unintentionally promotes weight gain and obesity. We 
recommend an improvement in the lifestyle of the 
present day population which is slowly and surely 
slipping into the epidemic of obesity. Preventing 
obesity would definitely help to boost the quality of life 
and thereby strengthen our nation's economy. 
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